VBI Vaccines Inc. (NASDAQ: VBIV) open the trading on July 14, 2021, with a bit cautious approach as it glided -3.88% to $2.97. During the day, the stock rose to $3.13 and sunk to $2.94 before settling in for the price of $3.09 at the close. Taking a more long-term approach, VBIV posted a 52-week range of $2.07-$6.93.The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 2.10%. Meanwhile, its Annual Earning per share during the time was 28.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 53.80%. This publicly-traded company’s shares outstanding now amounts to $251.29 million, simultaneously with a float of $197.16 million. The organization now has a market capitalization sitting at $755.00 million. At the time of writing, stock’s 50-day Moving Average stood at $3.37, while the 200-day Moving Average is $3.15.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 127 employees. It has generated 8,354 per worker during the last fiscal year. Meanwhile, its income per employee was -364,016. The stock had 0.26 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks gross margin was -919.79, operating margin was -4110.93 and Pretax Margin of -4357.21.
VBI Vaccines Inc. (VBIV) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. VBI Vaccines Inc.’s current insider ownership accounts for 3.27%, in contrast to 53.20% institutional ownership. According to the most recent insider trade that took place on Jun 29, this organization’s 10% Owner sold 646,257 shares at the rate of 3.80, making the entire transaction reach 2,455,777 in total value, affecting insider ownership by 0. Preceding that transaction, on Jun 09, Company’s 10% Owner sold 1,422,567 for 4.00, making the whole transaction’s value amount to 5,690,268. This particular insider is now the holder of 145,548 in total.
VBI Vaccines Inc. (VBIV) Earnings and Revenue Records
This company achieved a net margin of -4357.21 while generating a return on equity of -35.57.
VBI Vaccines Inc.’s EPS increase for this current 12-month fiscal period is 53.80% and is forecasted to reach -0.15 in the upcoming year.
VBI Vaccines Inc. (NASDAQ: VBIV) Trading Performance Indicators
Let’s observe the current performance indicators for VBI Vaccines Inc. (VBIV). It’s Quick Ratio in the last reported quarter now stands at 6.00. The Stock has managed to achieve an average true range (ATR) of 0.22. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 838.89.
In the same vein, VBIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.23, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.15 at the market close of one year from today.
Technical Analysis of VBI Vaccines Inc. (VBIV)
[VBI Vaccines Inc., VBIV] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 8.15% While, its Average True Range was 0.20.
Raw Stochastic average of VBI Vaccines Inc. (VBIV) in the period of the previous 100 days is set at 27.96%, which indicates a major rise in contrast to 2.19% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 57.95% that was lower than 67.59% volatility it exhibited in the past 100-days period.